Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1967 of 5804
-
Nose drops of pneumonia bacteria could pave way for better vaccines
Knowledge-focused CompletedThe 'Experimental Human Pneumococcal challenge' (EHPC) model is a way of putting drops of bacteria into the nose. Investigators have studied this model of putting bacteria in the nose safely in over 1500 volunteers over the past decade with no serious side effects and now want to…
Phase: NA • Sponsor: Liverpool School of Tropical Medicine • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Shockwaves aim to zap back pain without drugs
Symptom relief CompletedThis study aims to examine the effects of shockwave therapy on myofascial tissue (muscles, fascia, and connective tissue), focusing on pain reduction and improvement of mobility. The results will be compared with those of conventional manual physiotherapy. Myofascial tissue can …
Phase: NA • Sponsor: University Hospital Muenster • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
Can a School-Wide activity program boost teen health?
Disease control CompletedInvestigators will conduct a hybrid implementation-effectiveness trial of an adapted Comprehensive School Physical Activity Program (CSPAP) intervention. A clustered stepped wedge design will be used, with the duration of the trial being 3 years.
Phase: NA • Sponsor: Seattle Children's Hospital • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Ancient herb moutan cortex may soothe chemo nerve damage
Symptom relief TerminatedA randomized controlled trial was designed and conducted to confirm whether oral administration of the herb Moutan Cortex, which contains paeonol, can alleviate peripheral neuropathy in paclitaxel-treated cancer patients. This research project will validate our new preliminary fi…
Phase: NA • Sponsor: Taiwan Municipal An-Nan Hospital-China Medical University • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
New antibiotic cocktail aims to beat tough hospital pneumonia
Disease control CompletedThis study aims to compare treatment with Imipenem/Cilastatin-XNW4107 (IMI-XNW4107) with imipenem/cilastatin/relebactam (IMI/REL) in participants with hospital-acquired or ventilator-associated bacterial pneumonia (HABP or VAPB, respectively). The primary hypothesis is that IMI-X…
Phase: PHASE3 • Sponsor: Evopoint Biosciences Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New device targets recurrent brain tumors in early trial
Disease control Recruiting nowThe FRONTIER Study is a prospective, interventional, single-arm, multi-center, study to assess the safety and technical feasibility of TheraSphere GBM in patients with recurrent GBM.
Phase: PHASE1 • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Can a phone app boost PTSD therapy for veterans?
Symptom relief Recruiting nowThousands of mental health mobile applications (apps) are available but limited research has been conducted on their effectiveness. VA has been a leader in mental health mobile app development and must research whether these apps work, and if so, how? PE Coach is a well-designed …
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Registry aims to unlock secrets of rare brain tumor in NF1 patients
Knowledge-focused Recruiting nowThis study will collect medical records, scan results, and complete surveys to create a registry about people with a neurofibromatosis type 1-associated brain tumor (NF1-associated glioma). A registry is a collection of health information about individuals, and it is usually focu…
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Digital health coaching and remote monitoring tested for blood pressure control
Disease control CompletedHigh blood pressure, also known as hypertension, affects nearly half of all Americans and increases the risk for heart disease and stroke. Only about half of people with high blood pressure have it under control. New methods to control blood pressure are needed to reduce heart at…
Phase: NA • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New eye drop shows promise for dry eye sufferers in Late-Stage trial
Symptom relief CompletedThe purpose of this study is to evaluate the efficacy and safety of SI-614 ophthalmic solution compared with placebo in patients with dry eye
Phase: PHASE3 • Sponsor: Seikagaku Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Could a common numbing drug stop chronic pain after breast surgery?
Symptom relief Recruiting nowThe LOLIPOP Trial is a large (n=4,300 patients) pragmatic, international, multicentre, prospective, randomised, double blind, placebo-controlled, parallel assessment, safety and effectiveness superiority study.
Phase: PHASE3 • Sponsor: Monash University • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Can targeted addiction care prevent alcohol relapse after liver transplant?
Disease control OngoingAddiction care is "a la carte treatment", adapted to the motivation and time constrains of users. Thus, various types of psychotherapeutic follow-up can be considered, different addictolytic medications or opioid maintenance therapies can be offered during treatment and hospitali…
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New study tests faster hepatitis c detection for drug users
Knowledge-focused CompletedThis project aims to evaluate two strategies of Hepatitis C virus (HCV) testing compared to standard of care among people who inject drugs at needle and syringe program (NSP) services in Australia, to see if it can improve the number of people who start treatment following an HCV…
Phase: NA • Sponsor: Kirby Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Could a Mitochondria-Targeting pill help failing hearts?
Disease control CompletedDouble blind, randomised, placebo-controlled trial of MitoQ (mitoquinol mesylate) in 106 patients with dilated cardiomyopathy, examining the effect of reducing mitochondrial oxidative stress on myocardial energetics and myocardial function using 31-phosphorus magnetic resonance s…
Phase: PHASE2 • Sponsor: Imperial College London • Aim: Disease control
Last updated Jun 26, 2026 18:22 UTC
-
New TB drug cocktail shows promise in early trial
Disease control CompletedThis study measured the early bactericidal activity (EBA), safety, tolerability and pharmacokinetics of GSK3036656 in combination with either delamanid, bedaquiline or BTZ-043 and delamanid in combination with bedaquiline or standard of care, for 14 days, in participants with new…
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Queen club: can a loyalty card boost HIV prevention for teen girls?
Prevention CompletedThe goal of the study is to evaluate Malkia Klabu ("Queen Club") in Tanzania, a loyalty program intervention that creates adolescent girls and young women (AGYW)-friendly drug shops where AGYW can access HIV prevention services and contraception.
Phase: NA • Sponsor: University of California, San Francisco • Aim: Prevention
Last updated Jun 27, 2026 12:05 UTC
-
New anesthesia drug could replace propofol in surgeries
Symptom relief CompletedTo demonstrate HSK3486 0.4/0.2 mg/kg (0.4 mg/kg intravenous \[IV\] slow injection over 30 \[±5\] seconds for the first dose, an additional 0.2 mg/kg if needed) is non-inferior to propofol 2.0/1.0 mg/kg (2.0 mg/kg IV slow injection over 30 \[±5\] seconds for first dose, an additio…
Phase: PHASE3 • Sponsor: Haisco-USA Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
New drug duo aims to stall ovarian Cancer's return
Disease control OngoingStudy to evaluate the safety and activity of oregovomab and niraparib as a combinatorial immune priming strategy in subjects with platinum sensitive recurrent ovarian cancer.
Phase: PHASE2 • Sponsor: CanariaBio Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Chatbot vs. cigarettes: QuitBot shows promise in helping smokers quit
Disease control CompletedThis phase III trial compares two remote digital smoking cessation programs to see how well they work for quitting smoking.
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Can better Decision-Making save heart attack victims in shock?
Knowledge-focused OngoingThe CERAMICS study is designed to more clearly delineate the current care of acute myocardial infarction with cardiogenic shock (AMICS) patients who are treated with mechanical circulatory support (MCS) devices in the United States with significant experience in MCS, all of whom …
Sponsor: Henry Ford Health System • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC